Human Immunodeficiency Virus Clinical Trials in Aurora, Colorado
2 recruitingAurora, Colorado
Showing 1–2 of 2 trials
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 3
V+PSF-M for Tobacco Cessation in HIV Care in India
Smoking CessationSmoking, TobaccoHuman Immunodeficiency Virus
University of Colorado, Denver400 enrolled2 locationsNCT05786547